Funding for this research was provided by:
Cancer Research Coordinating Committee (CRN-19-586041)
Glioma Precision Medicine Program
Received: 31 May 2020
Accepted: 4 January 2021
First Online: 26 January 2021
Ethics approval and consent to participate
: Study protocols were approved by the UCSF Institutional Review Board. All clinical samples were analyzed in a de-identified fashion. All experiments were carried out in conformity to the principles set out in the WMA Declaration of Helsinki as well as the Department of Health and Human Services Belmont Report. Informed written consent was provided by all patients.
: None declared. The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.